, Tracking Stock Market Picks
Enter Symbol:
Ziopharm Oncology Inc (ZIOP) [hlAlert]

up 99.31 %

Ziopharm Oncology Inc (ZIOP) rated Buy with price target $9 by Global Hunter Securities

Posted on: Thursday,  Dec 15, 2011  9:25 AM ET by Global Hunter Securities

Global Hunter Securities rated Buy Ziopharm Oncology Inc (NASDAQ: ZIOP) on 12/15/2011, when the stock price was $4.35.
Since then, Ziopharm Oncology Inc has gained 99.31% as of 09/11/2015's recent price of $8.67.
If you would have followed this Global Hunter Securities's recommendation on ZIOP, you would have gained 99.31% of your investment in 1366 days.

ZIOPHARM Oncology, Inc. (ZIOPHARM) is a development-stage biopharmaceutical company. The Company focuses on developing and commercializing a portfolio of in-licensed cancer drugs that address unmet medical needs. The Company is focused on licensing and developing drug candidate families that are related to cancer therapeutics already on the market or in development and that can be developed in intravenous (IV) and/or oral forms of administration. As of December 31, 2008, it was in Phase I and Phase I/II studies for three product candidates known as darinaparsin (Zinapar ZIO-101), palifosfamide (Zymafos ZIO-201) and indibulin ( Zybulin ZIO-301).

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/15/2011 9:25 AM Buy
4.35 9.00
as of 12/30/2011
1 Week up  6.26 %
1 Month up  1.37 %
3 Months   
1 YTD up  1.37 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy